ΑΛΕΒΙΖΑΚΗ ΜΑΡΙΑ (2014)


Papers

 AssociationBetweenBRAFV600EMutationand MortalityinPatientsWithPapillaryThyroidCancer
 Birth Defects After Early Pregnancy Use of Antithyroid Drugs A Danish Nationwide Study
 Changes in Serum Adhesion Molecules, Chemokines, Cytokines, and Tissue Remodeling Factors in Euthyroid Women Without Thyroid Antibodies Who Are
 Cutting Edge Retrobulbar Inflammation,Adipogenesis, and Acute Orbital Congestion in a Preclinical Female Mouse Model of Graves’ Orbitopathy Indu
 Disease Severity and Radioactive Iodine Use for Thyroid Cancer
 Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels—Balancing Benefits and Risks
 Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
 Improved Levothyroxine Pharmacokinetics After Bariatric Surgery
 Is Lower Socioeconomic Status Associated with More Advanced Thyroid Cancer Stage at Presentation
 Maternal Thyroid Hormone Parameters during Early Pregnancy and Birth Weight The Generation R Study
 MicroRNA Expression Array Identifies Novel Diagnostic Markers for Conventional and Oncocytic Follicular Thyroid Carcinomas
 Multicenter Clinical Experience with the Afirma Gene Expression Classifier
 Nrf2 Is Commonly Activated in Papillary Thyroid Carcinoma, and It Controls Antioxidant Transcriptional Responses and Viability of Cancer Cells
 Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity after either recombinant human
 Persistent Subclinical Hypothyroidism and Cardiovascular Risk in the Elderly
 Prevalence and Natural History of Graves’ Orbitopathy in a Large Series of Patients With Newly
 Reversal of Cushing’s Syndrome by Vandetanib in Medullary Thyroid Carcinoma
 Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
 SRGAP1 Is a Candidate Gene for Papillary Thyroid Carcinoma Susceptibility
 Thyroid Hormones Are Associated With Cognitive Function Moderation by Sex, Race, and Depressive Symptoms
 Thyroid Nodule Size and Prediction of Cancer
 Thyrotropin-Blocking Autoantibodies and Thyroid-Stimulating Autoantibodies
 Unraveling the Genetic Predisposition to Differentiated Thyroid Carcinoma